Celgene logo Celgene Logo
Search

  • Canada
    • Australia
      • English
    • Austria
      • Deutsch
    • Belgium
      • Français
      • Nederlands
    • Brazil
      • Português
    • Canada
      • English
      • Français
    • Czech Republic
      • Čeština
    • Denmark
      • Dansk
    • Europe
      • English
    • Finland
      • Suomi
    • France
      • Français
    • Germany
      • Deutsch
    • Ireland
      • English
    • Italy
      • Italiano
    • Japan
      • 日本語
    • Luxembourg
      • Français
      • Nederlands
    • Mexico
      • Español
    • Netherlands
      • Nederlands
    • Norway
      • Norsk
    • Poland
      • Polski
    • Portugal
      • Português
    • Russia
      • Русский язык
    • South Korea
      • 한국어
    • Spain
      • Español
    • Sweden
      • Svenska
    • Switzerland
      • Deutsch
      • Français
    • Turkey
      • Türk
    • United Kingdom
      • English
    • United States
      • English
  • English
    • Français
  • About
    • Compliance
    • History
    • Global Office Locations
  • Product Information
    • Anti-counterfeiting
  • Research & Development
    • Product Pipeline
    • Medical Innovation
      • IMiDs
      • Anti-inflammatory Compounds
      • nab® Technology
    • R&D Locations
      • CITRE
      • Drug Discovery & Alliance Development
    • Clinical Trials
    • Celgene Medical Affairs
  • Responsibility
    • Patients & Communities
    • Commitment to Safety
      • Patient Safety
    • Global Health
  • Newsroom
    • Press Releases
  • Patients
    • Online Patient Resources
  • Investors
  • Careers
  • Contact Us
  • Creating an Innovative Biopharma Leader with Global Reach and Scale Creating an Innovative Biopharma Leader with Global Reach and Scale Creating an Innovative Biopharma Leader with Global Reach and Scale
    2019/03/13

    Creating an Innovative Biopharma Leader with Global Reach and Scale

    Bristol-Myers Squibb to acquire Celgene, bringing together two highly complementary companies with a shared focus on one mission—to discover, develop, and deliver innovative medicines for patients with serious diseases
    Read More
  • The Celgene Story The Celgene Story The Celgene Story
    2016/11/07

    Passion, Innovation, Courage: The Celgene Story

    Read More
  • Living Beyond Lymphoma Living Beyond Lymphoma Living Beyond Lymphoma
    2016/11/07

    Living Beyond Lymphoma

    Read More
  • Acute Myeloid Leukemia Remains a Struggle Acute Myeloid Leukemia Remains a Struggle Acute Myeloid Leukemia Remains a Struggle
    2016/11/07

    Acute Myeloid Leukemia Remains a Struggle Progress has been slow, but there are reasons to be hopeful

    Read More

Creating an Innovative Biopharma Leader with Global Reach and Scale
2019/03/13

Creating an Innovative Biopharma Leader with Global Reach and Scale

Facing Each Day with Pancreatic Cancer, Hand-in-Hand
2016/11/23

Facing Each Day with Pancreatic Cancer, Hand-in-Hand

A Decade of Progress in Myeloma, And More to Come
2016/11/07

A Decade of Progress in Myeloma, And More to Come

Talking with Others with Rare Diseases Empowers Patients
2016/11/07

Talking with Others with Rare Diseases Empowers Patients

A Challenging yet Rewarding Journey Towards a Myeloma Cure
2016/11/07

A Challenging yet Rewarding Journey Towards a Myeloma Cure

Patients are Waiting: Supporting the Pancreatic Cancer Community
2016/11/22

Patients are Waiting: Supporting the Pancreatic Cancer Community

  • About
    • Compliance
    • History
    • Global Office Locations
  • Product Information
    • Anti-counterfeiting
  • Research & Development
    • Product Pipeline
    • Medical Innovation
    • R&D Locations
    • Clinical Trials
    • Celgene Medical Affairs
  • Responsibility
    • Patients & Communities
    • Commitment to Safety
    • Global Health
  • Newsroom
    • Press Releases
  • Patients
    • Online Patient Resources
  • Investors
  • Careers
  • Contact Us
  • Privacy Policy
  • Site Map

Search News

Global Press Releases

See all press releases 

Most Read

  • Our Commitment to Multiple Sclerosis

  • Patients are Waiting: Supporting the Pancreatic Cancer Community


Global Office Locations

world map

HAVE A QUESTION OR CONCERN?
CONTACT US

  • About
  • Product Information
  • Research & Development
  • Responsibility
  • Newsroom
  • Patients
  • Investors
  • Careers
  • Pipeline
  • Privacy Policy
  • Legal Notice
  • Site Map



This Site Is Intended For Canadian Audiences.

  • Copyright © 2021 Celgene Corporation
    A Bristol Myers Squibb Company
  • Accessibility
    Policy
  • Multi-Year
    Accessibility
  • Legal
    Notice
  • Privacy
    Policy
  • Newsroom
    • Press Releases
X

You are now leaving Celgene.ca. Celgene is not responsible for, and does not in any way oversee, manage, operate, provide or endorse, any third party website or any products, services or content on such third party website. Celgene’s Terms of Use and Privacy Policy are not applicable to any third party website and so Celgene recommends that you review the terms of use, privacy and/or data security policies of any such third party websites.

Continue

To view

Cancel

To return to www.Celgene.ca

These products may not be approved and/or licensed in all countries where this website is accessible. For information about Celgene products and services in countries other than the U.S., please contact the local office (as listed under the Global Network).

Continue

To view

Cancel

To return to www.Celgene.com

Celgene is now part of Bristol-Myers Squibb


Select CONTINUE for information about Celgene.

Select BMS to learn more about Bristol-Myers Squibb.



CONTINUE BMS